Finally: A Missing Link Between Vitamin D and Prostate Cancer

A University of Colorado Cancer Center study recently published in the journal Prostate offers compelling evidence that inflammation may be the link between Vitamin D and prostate cancer. Specifically, the study shows that the gene GDF-15, known to be upregulated by Vitamin D, is notably absent in samples of human prostate cancer driven by inflammation.

Read the rest of this entry

Does Study of Down Syndrome Hold a Possible Cancer Cure?

Remarkably, people with Down syndrome have an increased incidence of leukemia but a much lower incidence of solid tissue tumors. What is it about the extra copy of chromosome 21 that protects them from solid tumors but predisposes them to blood cancers?

Read the rest of this entry

CU Cancer Center director elected to Institute of Medicine

AURORA, Colo –  Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center,…

Read the rest of this entry

Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries

Study of skin conditions shows mortality rates for measles, syphilis, Ebola hundreds of times higher in developing countries than in developed countries. Study writes that findings, “Highlight the importance of monitoring disease burden in the developing world even when the burden is low.”

Read the rest of this entry

Breast cancer survivors sleeping better….online?

AURORA, Colo. – Dozens of breast cancer survivors living in rural and frontier areas of…

Read the rest of this entry

Brian Kavanagh: Edits special issue of oncology journal and new textbook

By: Danielle Zieg Brian Kavanagh, professor of Radiation Oncology, School of Medicine, recently edited two…

Read the rest of this entry

First Annual Scope It Out 5K Raises Colon Cancer Awareness

The first annual Scope It Out 5K run/walk to raise awareness for colon cancer was…

Read the rest of this entry

After a year off, Gift of Life and Breath 5K makes a strong return.

Lung cancer is the leading cause of cancer-related deaths in the United States for men…

Read the rest of this entry

NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer

The New England Journal of Medicine reports positive results of a phase 1 clinical trial of the drug crizotinib against the subset of lung cancer marked by rearrangement of the gene ROS1.

Read the rest of this entry

CU Cancer Center Reports Results of Phase 1 Clinical Trial of Avastin with Immune Drug Against Solid Tumors

Bevacizumab (Avastin) slows the growth of new blood vessels that tumors need to supply themselves with nutrients. Will it work better in combination with the new immunotherapy drug MPDL3280A?

Read the rest of this entry